Pediatric Thrombosis

ISTH Academy, Char Witmer & Heleen van Ommen, 286682

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study

ISTH Academy, Marcello Di Nisio, 286267

Corrigendum

ISTH Academy, Session Speakers, 286268

Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P‐selectin predict occult cancer after unprovoked venous thromboembolism

ISTH Academy, Fredrik Stangenberg, 286269

Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies

ISTH Academy, Delphine Borgel, 286270

Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population

ISTH Academy, , 286271

Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients

ISTH Academy, Bhavya Doshi, 286272

Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk

ISTH Academy, , 286273

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study

ISTH Academy, Borge Nordestgaard, 286274

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance

ISTH Academy, Mareike Lankeit, 286275

What The Neighbors Say

ISTH Academy, Session Speakers, 286276

Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII‐deficient mice

ISTH Academy, Esther J. Cooke, 286277

Thrombin: Coagulation's master regulator of innate immunity

ISTH Academy, Edward Conway, 286278

Transgender patients and the role of the coagulation clinician

ISTH Academy, Mareike Lankeit, 286279

International Society on Thrombosis and Haemostasis core curriculum project: Core competencies in laboratory thrombosis and hemostasis

ISTH Academy, Karen Moffat, 286280

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Session Speakers, 286281

Glucose metabolism affects coagulation factors: The NEO study

ISTH Academy, Astrid Van Hylckama Vlieg, 286282

Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC

ISTH Academy, Bernard Tardy, 286283

A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process

ISTH Academy, Pierre-Emmanuel Morange, 286284

Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy?

ISTH Academy, Mareike Lankeit, 286285

Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation

ISTH Academy, Toshiaki Iba, 286286

Issue Information

ISTH Academy, Session Speakers, 286287

The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia

ISTH Academy, Allyson M. Pishko, 286288

Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis

ISTH Academy, Christelle Le Gall‐Ianotto, 286289

Defective fibrin deposition and thrombus stability in Bambi mice are mediated by elevated anticoagulant function

ISTH Academy, Isabelle Salles-Crawley, 286290

Temporal map of the pig polytrauma plasma proteome with fluid resuscitation and intravenous vitamin C treatment

ISTH Academy, Ramesh Natarajan, 286291

Purification of silica‐free DNA and characterization of its role in coagulation

ISTH Academy, Paul Kim, 286292

Thrombophilia testing: What can be tested & What should be tested

ISTH Academy, Joost Meijers and Saskia Middeldorp, 273715

Recognizing Excellence in Peer Review

ISTH Academy, Session Speakers, 286318

The risk of arterial thromboembolic events after cancer diagnosis

ISTH Academy, Babak B. Navi, 286319

Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects

ISTH Academy, Christian Gachet, 286320

Hemostatic complications associated with ventricular assist devices

ISTH Academy, Thomas Deloughery, 286321

Blood platelet research in autism spectrum disorders: In search of biomarkers

ISTH Academy, Kathleen Freson, 286322

Corrigendum

ISTH Academy, Session Speakers, 286323

Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions

ISTH Academy, Mateo Porres‐Aguilar, 286324

Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international study

ISTH Academy, Mateo Porres‐Aguilar, 286325

ISSUE INFORMATION

ISTH Academy, Session Speakers, 286326

Limited factor VIIa surface localization requirement of the factor VIIa–induced overall thrombin generation in platelet‐rich hemophilia A plasma

ISTH Academy, Vincenzo Musolino, 286327

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome

ISTH Academy, Marie Christine Alessi, 286328

Characterization of a transgenic mouse model of chronic conditional platelet depletion

ISTH Academy, Randall Worth, 286329

Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability

ISTH Academy, Anne Angelillo- Scherrer, 286330

#WomenInMedicine: Progress in gender equity at Research and Practice in Thrombosis and Haemostasis

ISTH Academy, Mary Cushman, 286331

Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit

ISTH Academy, Erich De Paula, 286332

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017

ISTH Academy, Pamela L. Lutsey, 286333

Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells

ISTH Academy, Ruben Bierings, 286334

Corrigendum

ISTH Academy, Session Speakers, 286335

Blood platelets: Circulating mirrors of neurons?

ISTH Academy, Ilaria Canobbio, 286336

Post‐thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool

ISTH Academy, Maria Laura Avila, 286337

Erratum

ISTH Academy, Session Speakers, 286338

Factor XII – What's important but not commonly thought about

ISTH Academy, Alvin Schmaier, 286339

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study

ISTH Academy, Matthew Wanat, 286340

Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant

ISTH Academy, Osamu Kumano, 286341

Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China

ISTH Academy, Runhui Wu, 286342

The experience of postpartum bleeding in women with inherited bleeding disorders

ISTH Academy, Michelle Sholzberg, 286343

Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta‐analysis

ISTH Academy, Jonathan Stine, 286344

Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis

ISTH Academy, Maha Othman, 286345

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation

ISTH Academy, Oliver Koenigsbruegge, 286346

Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism

ISTH Academy, Robin Amanda Liang, 286243

Managing sepsis‐associated coagulopathy remains an enigma

ISTH Academy, Jecko Thachil, 286244

Hypothermia‐induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model

ISTH Academy, Hiroki Tanaka, 286245

Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self‐propelling particles

ISTH Academy, Amedeo Piazza, 286246

Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

ISTH Academy, Sylvia Haas, 286247

Thromboembolism in major joint prosthetic surgery: False or fact

ISTH Academy, Ola E. Dahl, 286248

Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey

ISTH Academy, Hannah Cohen, 286249

Definitions, adjudication, and reporting of pulmonary embolism–related death in clinical studies: A systematic review

ISTH Academy, Farrukh Awan, 286250

Platelet‐derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice

ISTH Academy, Matthew Neal, 286251

Trauma‐targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model

ISTH Academy, Anirban Sen Gupta, 286252

Heparin‐induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants

ISTH Academy, Uri Pollak, 286253

The role of a specialist bridging service. A New Zealand prospective study of 600 patients

ISTH Academy, Ruell Jackie, 286254

ISTH news and updates: Join the ISTH today

ISTH Academy, Session Speakers, 286255

Toll‐like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis

ISTH Academy, Wei Chao, 286256

Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability

ISTH Academy, Virginie Siguret-Depasse, 286257

Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome

ISTH Academy, Anetta Undas, 286258

The potential of serpins for future treatment for haemophilia

ISTH Academy, Josefin Ahnstrom, 286259

What The Neighbors Say

ISTH Academy, Session Speakers, 286260

George J. Broze Jr., MD (3 August 1946–19 June 2019)

ISTH Academy, Session Speakers, 286261

Engineering a protein Z‐dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment

ISTH Academy, Xin Huang, 286262

Issue Information

ISTH Academy, Session Speakers, 286263

Tranexamic acid for trauma: Repackaged and redelivered

ISTH Academy, Keith B. Neeves, 286264

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

ISTH Academy, Tzu Fei Wang, 286265

Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion

ISTH Academy, Hilde Skuterud Wik, 286266

Risk assessment models: thromboprophylaxis & VTE recurrence

ISTH Academy, Lara Roberts and Sabine Eichinger, 273714

Inhibitors in hemophilia: Risk factors, biomarkers and other predictors

ISTH Academy, Samantha Gouw and Rolf Carl Ljung, 273713

Physical proximity and functional cooperation of glycoprotein 130 and glycoprotein VI in platelet membrane lipid rafts

ISTH Academy, Isabelle ODIN, 286214

Mice, men, and differences therein

ISTH Academy, Alisa Wolberg, 286215

Professor Helge Stormorken, 1922‐2019

ISTH Academy, Session Speakers, 286216

Corrigendum

ISTH Academy, Session Speakers, 286217

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?

ISTH Academy, Suzanne Cannegieter, 286218

Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH

ISTH Academy, Gary Moore, 286219

No resistance to activated protein C resistance—but choose wisely

ISTH Academy, Rita Selby, 286220

Response to Letter to the Editor submitted by Dr. Wada and Dr. Yamakawa re: Trauma‐induced coagulopathy: The past, present, and future

ISTH Academy, Session Speakers, 286221

Sex matters: Practice 5P's when treating young women with venous thromboembolism

ISTH Academy, DARIO ZAZZARO, 286222

Genomic momentum for hemostasis and thrombosis

ISTH Academy, Session Speakers, 286230

Erratum

ISTH Academy, Session Speakers, 286231

Issue Information

ISTH Academy, Session Speakers, 286232

Cell surface expression of HLA I molecules as a marker of young platelets

ISTH Academy, Blandine Maître, 286233

Variability of von Willebrand factor‐related parameters in endothelial colony forming cells

ISTH Academy, Jeroen Eikenboom, 286234

Role of RXRβ in platelet function and arterial thrombosis

ISTH Academy, benjamin taisne, 286235

New insights into cytoskeletal remodeling during platelet production

ISTH Academy, Wolfgang Bergmeier, 286236

Trauma‐induced coagulopathy: The past, present, and future: A comment

ISTH Academy, Puja Soni, 286237